Change of Management in Evonik’s Health & Nutrition Business Unit
16-Mar-2009 -
Dr. Hans-Josef Ritzert, head of Evonik Industries AG’s Catalysts Business Line, will take over management of the Exclusive Synthesis & Amino Acids Business Line effective April 1, 2009. His predecessor, Dr. Rudolf Hanko, will leave the company on May 1, 2009, to assume the position of CEO at ...
amino acids
catalysts
Evonik Industries
+1